Facebook Twitter YouTube LinkedIn Reddit

Valeo Pharma Inc.

Disclaimer: All stock information on InvestorIntel.com is currently being fed from multiple sources and is updated automatically every 10-minutes. The information on this site is for information purposes only and InvestorIntel Corp. is neither responsible nor liable for the accuracy of this data.

InvestorIntel Features on Valeo Pharma Inc.

Valeo Pharma is cashed up and ready to expand as COVID restrictions end

Are we starting to see the beginning of the end of COVID’s reign of terror over humanity? I certainly hope […]

Valeo Pharma’s Redesca™ rollout is progressing rapidly, proving the value of its business model, as its revenue grows 280% in Q3, 2021

Valeo Pharma Inc. (CSE: VPH | OTCQB: VPHIF | FSE: VP2) (“Valeo”) is a specialty pharmaceutical marketing company dedicated to […]

Steve Saviuk on Valeo Pharma’s Redesca, an injectable anticoagulant drug that just commenced shipment in Canada

In a recent InvestorIntel interview, Tracy Weslosky spoke with Steve Saviuk, CEO of Valeo Pharma Inc. (CSE: VPH | OTCQB: […]

Company Overview

Team | Website

Valeo Pharma is a pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on Respirology, Neurodegenerative Diseases, Oncology and other specialty products. Headquartered in Kirkland, Quebec, Valeo Pharma has the full capability and complete infrastructure to register and properly manage its growing product portfolio through all stages of commercialization.

News Releases

View All News

Facebook Twitter YouTube LinkedIn Reddit